BABA vs PRTS

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

PRTS exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a high probability of continued financial deterioration. While the stock trades at a very low Price/Sales multiple (0.12), this is offset by negative profit margins, declining year-over-year revenue (-9.80%), and a catastrophic 5-year price decline of 94.5%. Recent short-term price gains appear speculative and are not supported by the underlying operational health or the poor Quick Ratio (0.41), which suggests significant liquidity risk tied to inventory.